Frederick W. Driscoll, Chief Financial Officer at Flexion Therapeutics Inc (FLXN), bought 2,500 shares at $9.87 ($25K) on 2016-05-17, disclosed to the SEC on 2016-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| NK | SELL | 2020-08-13 | $1.2M | — | Filing → |
| MEIP | BUY | 2019-12-20 | $100K | — | Filing → |
| FLXN | SELL | 2017-03-24 | $69K | — | Filing → |